Parasit Vectors. 2009 Jun 25;2(1):27. doi: 10.1186/1756-3305-2-27.
In silico analysis of the cyclophilin repertoire of apicomplexan parasites.
Parasites & vectors
Jürgen Krücken, Gisela Greif, Georg von Samson-Himmelstjerna
Affiliations
Affiliations
- Institute for Parasitology, University of Veterinary Medicine Foundation, Bünteweg 17, 30559 Hannover, Germany. [email protected].
PMID: 19555495
PMCID: PMC2713222 DOI: 10.1186/1756-3305-2-27
Abstract
BACKGROUND: Cyclophilins (Cyps) are peptidyl cis/trans isomerases implicated in diverse processes such as protein folding, signal transduction, and RNA processing. They are also candidate drug targets, in particular for the immunosuppressant cyclosporine A. In addition, cyclosporine is known to exhibit anti-parasitic effects on a wide range of organisms including several apicomplexa. In order to obtain new non-immunosuppressive drugs targeting apicomplexan cyclophilins, a profound knowledge of the cyclophilin repertoire of this phylum would be necessary.
RESULTS: BLAST and maximum likelihood analyses identified 16 different cyclophilin subfamilies within the genomes of Cryptosporidium hominis, Toxoplasma gondii, Plasmodium falciparum, Theileria annulata, Theileria parva, and Babesia bovis. In addition to good statistical support from the phylogenetic analysis, these subfamilies are also confirmed by comparison of cyclophilin domain architecture. Within an individual genome, the number of different Cyp genes that could be deduced varies between 7-9 for Cryptosporidia and 14 for T. gondii. Many of the putative apicomplexan cyclophilins are predicted to be nuclear proteins, most of them presumably involved in RNA processing.
CONCLUSION: The genomes of apicomplexa harbor a cyclophilin repertoire that is at least as complex as that of most fungi. The identification of Cyp subfamilies that are specific for lower eukaryotes, apicomplexa, or even the genus Plasmodium is of particular interest since these subfamilies are not present in host cells and might therefore represent attractive drug targets.
References
- Parasitology. 1992;105 Suppl:S25-40 - PubMed
- Bioinformatics. 2007 Nov 1;23(21):2947-8 - PubMed
- Parasitology. 2006 Jun;132(Pt 6):867-82 - PubMed
- Essays Biochem. 2005;41:15-30 - PubMed
- Int J Parasitol. 2006 Mar;36(3):261-76 - PubMed
- Exp Parasitol. 2008 Feb;118(2):275-9 - PubMed
- Genome Biol. 2005;6(7):226 - PubMed
- BMC Genomics. 2006 Sep 22;7:244 - PubMed
- Mol Biochem Parasitol. 2003 Dec;132(2):59-66 - PubMed
- Front Biosci. 2004 Sep 01;9:2420-46 - PubMed
- Biochem Pharmacol. 1994 Aug 3;48(3):495-503 - PubMed
- Int J Parasitol. 2003 Aug;33(9):987-96 - PubMed
- Bioinformatics. 2001;17 Suppl 1:S140-8 - PubMed
- Antimicrob Agents Chemother. 1984 Jul;26(1):26-30 - PubMed
- Agents Actions. 1981 Jul;11(4):380-3 - PubMed
- Nat Protoc. 2007;2(4):953-71 - PubMed
- RNA. 1998 Feb;4(2):127-41 - PubMed
- Traffic. 2008 Feb;9(2):166-75 - PubMed
- New Biol. 1992 May;4(5):421-9 - PubMed
- Mol Biol Evol. 2007 Sep;24(9):1926-33 - PubMed
- Science. 2007 Sep 28;317(5846):1921-6 - PubMed
- FEBS J. 2008 May;275(9):2283-95 - PubMed
- Mol Biochem Parasitol. 1999 Apr 30;99(2):167-81 - PubMed
- Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W327-31 - PubMed
- Front Biosci. 2000 Sep 01;5:D821-36 - PubMed
- Yeast. 2005 Sep;22(12):927-45 - PubMed
- Vet Parasitol. 2004 May 7;121(1-2):65-77 - PubMed
- Mol Cell Biol. 2006 Jul;26(14):5528-43 - PubMed
- Biochim Biophys Acta. 1992 Feb 14;1138(2):115-21 - PubMed
- Proteomics. 2004 Jun;4(6):1581-90 - PubMed
- Nature. 2005 Mar 31;434(7033):658-62 - PubMed
- Nature. 2005 Mar 24;434(7032):462-9 - PubMed
- J Antimicrob Chemother. 2007 Feb;59(2):197-203 - PubMed
- Genetics. 2000 Dec;156(4):1503-17 - PubMed
- Trends Biochem Sci. 1999 Jan;24(1):34-6 - PubMed
- Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12005-10 - PubMed
- J Biol Chem. 2006 Jun 9;281(23):15900-8 - PubMed
- Nucleic Acids Res. 2009 Jan;37(Database issue):D205-10 - PubMed
- Antimicrob Agents Chemother. 1997 Sep;41(9):1859-66 - PubMed
- Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13093-8 - PubMed
- Infect Immun. 1987 Jul;55(7):1616-21 - PubMed
- Exp Parasitol. 1989 Apr;68(3):289-96 - PubMed
- Antimicrob Agents Chemother. 1998 Apr;42(4):843-8 - PubMed
- Microbiol Rev. 1993 Dec;57(4):953-94 - PubMed
- Nature. 2001 Nov 22;414(6862):450-3 - PubMed
- RNA. 1997 Dec;3(12):1374-87 - PubMed
- J Biol Chem. 2005 Jul 1;280(26):24308-14 - PubMed
- Infect Immun. 1982 Sep;37(3):1093-100 - PubMed
- Gene. 2001 Dec 12;280(1-2):19-26 - PubMed
- Cell Mol Life Sci. 1999 Mar;55(3):423-36 - PubMed
- Syst Biol. 2003 Oct;52(5):696-704 - PubMed
- Mol Biochem Parasitol. 2005 May;141(1):29-37 - PubMed
- RNA. 2006 Apr;12(4):631-43 - PubMed
- Mol Biol Evol. 2007 Aug;24(8):1596-9 - PubMed
- Comp Funct Genomics. 2005;6(5-6):277-300 - PubMed
- Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4430-5 - PubMed
- J Biol Chem. 2002 Apr 26;277(17):14925-32 - PubMed
- Bioinformatics. 2001 Sep;17(9):847-8 - PubMed
- Genome Res. 2004 Oct;14(10B):2162-8 - PubMed
- Agents Actions. 1981 Dec;11(6-7):770-3 - PubMed
- Infect Immun. 2005 Aug;73(8):5093-100 - PubMed
- Eur J Biochem. 1995 Sep 15;232(3):765-72 - PubMed
- Trends Parasitol. 2006 Apr;22(4):168-74 - PubMed
- Cell Mol Life Sci. 2006 Dec;63(24):2889-900 - PubMed
- Trop Med Parasitol. 1991 Dec;42(4):375-80 - PubMed
- Genome Res. 2002 Oct;12(10):1619-23 - PubMed
- Brief Bioinform. 2008 Jul;9(4):299-306 - PubMed
- Comput Appl Biosci. 1992 Jun;8(3):275-82 - PubMed
- Eur J Biochem. 1996 Nov 1;241(3):779-86 - PubMed
- FEBS Lett. 2008 Jul 9;582(16):2345-51 - PubMed
- Rev Physiol Biochem Pharmacol. 2003;148:105-50 - PubMed
Publication Types